Viewing Study NCT05810792


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2025-12-29 @ 5:18 PM
Study NCT ID: NCT05810792
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-11-22
First Post: 2023-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer
Sponsor: Sahlgrenska University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
None Surgery View
None Metastasis View
None Immunosuppression View
Keywords: